The aryl hydrocarbon receptor (AhR), an important ligand‐activated transcription factor, has been reported to accelerate atherosclerosis through triggering vascular inflammation and promoting foam cell formation (Dahlem et al. 2020; Wu et al. 2011). The gene discussed is AHR; the disease is atherosclerosis.